Brian Wells to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Brian Wells has written about Dipeptidyl-Peptidase IV Inhibitors.
Connection Strength
0.033
-
Kannan S, Pantalone KM, Matsuda S, Wells BJ, Karafa M, Zimmerman RS. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic. J Diabetes. 2016 Mar; 8(2):279-85.
Score: 0.033